Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. STE
STE logo

STE Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy STERIS plc (STE) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
202.610
1 Day change
1.61%
52 Week Range
269.440
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Based on the investor's beginner level, long-term strategy, and available investment range, STERIS plc (STE) is a good buy. Despite recent technical weakness, the positive sentiment from Congress trading activity, the analyst's attractive valuation view, and the company's potential for recovery make it a suitable long-term investment.

Technical Analysis

The technical indicators show bearish momentum with the MACD histogram below 0 and negatively contracting, RSI at 34.745 in the neutral zone, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 200.296, and resistance is at 206.55. The stock is trading close to its support level, suggesting limited downside risk.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Congress trading data indicates heavy buying activity with 5 purchase transactions totaling $0.5M to $7.5M. Analysts view the stock as attractive at current levels despite recent underperformance. The stock has a 3.23% chance of gaining in the next month based on similar candlestick patterns.

Neutral/Negative Catalysts

  • Technical indicators are bearish, and the stock has a 60% chance of declining by -0.58% in the next day and -1.52% in the next week. No recent news or financial data is available to provide additional clarity.

Financial Performance

No financial data available for the latest quarter.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

KeyBanc analyst Brett Fishbin lowered the price target to $269 from $291 but maintained an Overweight rating. The firm sees the stock as attractive at current levels despite Q4 results being below expectations.

Wall Street analysts forecast STE stock price to rise
Analyst Rating
0
Wall Street analysts forecast STE stock price to rise
Buy
Hold
Sell
0
Current: 199.400
sliders
Low
0
Averages
0
High
0
0
Current: 199.400
sliders
Low
0
Averages
0
High
0
KeyBanc
Brett Fishbin
Overweight
downgrade
$291 -> $269
AI Analysis
2026-05-13
Reason
KeyBanc
Brett Fishbin
Price Target
$291 -> $269
AI Analysis
2026-05-13
downgrade
Overweight
Reason
KeyBanc analyst Brett Fishbin lowered the firm's price target on Steris to $269 from $291 given lower peer multiples, while keeping an Overweight rating on the shares. The firm notes Q4 results were below expectations, but KeyBanc was mostly encouraged by the initial FY27 outlook and views shares as attractive at current levels.
Morgan Stanley
Ioannis Masvoulas
Equal Weight
maintain
2026-01-08
Reason
Morgan Stanley
Ioannis Masvoulas
Price Target
2026-01-08
maintain
Equal Weight
Reason
Morgan Stanley analyst Ioannis Masvoulas raised the firm's price target on Stora Enso to EUR 10.90 from EUR 10.70 and keeps an Equal Weight rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for STE
Unlock Now

People Also Watch